Systematic Assessment of Treatment Effectiveness for Long-Term Management of Stable Atrial Tachycardia in Inpatient and Outpatient Environments (SATELLITE)

November 18, 2025 updated by: Christian Meyer, Evangelical Hospital Düsseldorf
The aim is to analyze long-term outcomes in a multicenter observational registry including patients undergoing atrial tachycardia rhythm control.

Study Overview

Status

Active, not recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Germany
      • Düsseldorf, Germany
        • EVK Düsseldorf
      • Hamburg, Germany
        • University Hospital Hamburg-Eppendorf
      • Hamburg, Germany
        • Asklepios Hospital St. Georg
      • Karlsruhe, Germany
        • Municipal Clinical Center Karlsruhe
      • Münster, Germany
        • University Hospital Münster

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients undergoing atrial tachycardia rhythm control

Description

Inclusion Criteria:

Patients undergoing atrial tachycardia rhythm control

Exclusion Criteria:

Follow-up <30 days after atrial tachycardia rhythm control

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Patients undergoing atrial tachycardia rhythm control
Patients undergoing catheter ablation and/or electrocardioversion for atrial tachycardia

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Mortality, stroke and cardiovascular hospitalization
Time Frame: From AT rhythm control through study completion, an average of 2 years
From AT rhythm control through study completion, an average of 2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Evangelical Hospital Düsseldorf

Collaborators

Universitätsklinikum Hamburg-Eppendorf
Staedtisches Klinikum Karlsruhe
Asklepios Klinik St. Georg
Münster University Hospital, Germany

Investigators

  • Principal Investigator: Christian Meyer, MD, MA, EVK, Düsseldorf

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2024

Primary Completion (Estimated)

January 1, 2026

Study Completion (Estimated)

August 1, 2026

Study Registration Dates

First Submitted

November 15, 2025

First Submitted That Met QC Criteria

November 18, 2025

First Posted (Actual)

November 20, 2025

Study Record Updates

Last Update Posted (Actual)

November 20, 2025

Last Update Submitted That Met QC Criteria

November 18, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SATELLITE

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Albania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe